Cleared Traditional

K033262 - MOLECULAR ADSORBENT RECIRCULATING SYSTE...

K033262 is an FDA 510(k) clearance for MOLECULAR ADSORBENT RECIRCULATING SYSTE..., manufactured by Gambro Renal Products. The device is a Class 2 Gastroenterology & Urology device with product code FLD cleared through the Traditional 510(k) pathway after a 596-day FDA review.

K033262 · Gambro Renal Products · Gastroenterology & Urology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2005
Decision
596d
Days
Class 2
Risk

K033262 is an FDA 510(k) clearance for the MOLECULAR ADSORBENT RECIRCULATING SYSTEM (MARS). Classified as Apparatus, Hemoperfusion, Sorbent (product code FLD), Class II - Special Controls.

Submitted by Gambro Renal Products (Lakewood, US). The FDA issued a Cleared decision on May 27, 2005 after a review of 596 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.5870 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Gastroenterology & Urology submissions.

View all Gambro Renal Products devices

FDA 510(k) Submission Details - K033262

510(k) Number K033262 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 09, 2003
Decision Date May 27, 2005
Days to Decision 596 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
466d slower than avg
Panel avg: 130d · This submission: 596d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FLD Device Classification - Class 2, Special Controls

Product Code FLD Apparatus, Hemoperfusion, Sorbent
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.5870
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.